Smith Group Asset Management, LLC Collegium Pharmaceutical, Inc Transaction History
Smith Group Asset Management, LLC
- $1.74 Trillion
- Q3 2025
A detailed history of Smith Group Asset Management, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Smith Group Asset Management, LLC holds 19,588 shares of COLL stock, worth $900,656. This represents 0.04% of its overall portfolio holdings.
Number of Shares
19,588
Previous 19,012
3.03%
Holding current value
$900,656
Previous $562 Million
21.91%
% of portfolio
0.04%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding COLL
# of Institutions
259Shares Held
37.6MCall Options Held
53.7KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$266 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.83MShares$130 Million1.63% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.39MShares$110 Million1.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.23MShares$102 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.6MShares$73.5 Million0.08% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.57B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...